DRKS00032351招募中不适用
German prospective registry for patients with chronic myeloid leukemia (CML) previously treated with =2 TKIs switched to another TKI (ASCiminib or ANY ATP-competitive TKI) - ASCANY
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Ph+ or BCR::ABL1 -fusion gene positive CML in chronic phase
- •2. Prior treatment with = 2 TKIs
- •3. Decision of the treating physician to switch to a TKI approved for third line CML treatment; the TKI has already been selected by the physician at time of enrollment
- •4. Switch due to warning or failure (adapted from the 2020 ELN recommendations ) or due to intolerance to the most recent TKI therapy
- •5. Age = 18 years at the time of change to a new TKI-treatment
- •6. Signed informed consent prior to participation in this registry
排除标准
- •Existing T315I mutation
研究者
相似试验
招募中
不适用
German epidemiological and clinical study of patients with pityriasis rubra pilarisL44.0Pityriasis rubra pilarisDRKS00027232niversitätsmedizin Göttingen200
招募中
不适用
The prospective cohort study in patients with Chronic obstructive pulmonary diseaseKCT0005032Inje University100
招募中
不适用
CerclAge REgisterstudy Germany (CARE Studie): a multicenter, prospective, register study for women with risk for premature delivery status post secondary and emergency cerlageCervical incompetence, preterm birth, premature labor, CerclageDRKS00029021Deutsche Gesellschaft für Perinatale Medizin (DGPM) e.V.Geschäftsstelle c/o Conventus Congressmanagement & Marketing GmbH500
招募中
不适用
German prospective register study for detecting the treatment of gynecological sarcomas in clinical routineeimyosarcomendometrial stromal sarcomaundifferenciated endometrial stroma sarcomC49C54Malignant neoplasm of other connective and soft tissueMalignant neoplasm of corpus uteriDRKS00009240OGGO e.V.1,200
终止
不适用
German National Registry for NSSKidney NeoplasmNCT04681690Association of Urologic Oncology (AUO)137